ATRA
Atara Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.69
−0.21%Forward multiples
Based on analyst estimates
- P/E forward
- 14.99x
- P/E 2026E
- —
- P/E 2027E
- 10.34x
- P/E 2028E
- 22.24x
- P/S forward
- 2.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.63x
- Price / sales
- 15.70x
- Price / cash flow
- -4.44x
Enterprise value
- Enterprise value
- $97.3M
- EV / sales
- 15.70x
- EV / EBITDA
- -7.13x
- EV / EBIT
- -6.84x
- Market cap
- $97.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026